Stay updated on EDP-305 Safety and Efficacy in NASH Clinical Trial
Sign up to get notified when there's something new on the EDP-305 Safety and Efficacy in NASH Clinical Trial page.

Latest updates to the EDP-305 Safety and Efficacy in NASH Clinical Trial page
- Check3 days agoChange DetectedRemoved the 'Non-alcoholic fatty liver disease' topic and the related 'MedlinePlus Genetics' topic from the page.SummaryDifference0.1%

- Check10 days agoNo Change Detected
- Check18 days agoChange DetectedRevision from v3.4.3 to v3.5.0. No visible changes to the study details or navigation.SummaryDifference0.0%

- Check25 days agoChange DetectedThe page revision updated from v3.4.2 to v3.4.3.SummaryDifference0.0%

- Check53 days agoChange DetectedA new site Revision: v3.4.2 tag was added and the previous Revision: v3.4.1 tag was removed. The funding-lapse notice previously displayed has been removed.SummaryDifference0.2%

- Check61 days agoChange DetectedAdded a site-wide notice about government funding lapse and NIH Clinical Center status, and updated the site revision to v3.4.1 (replacing v3.4.0). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check68 days agoChange DetectedAdded a glossary toggle, a new 'Last Update Submitted that Met QC Criteria' label, No FEAR Act Data information, and revision indicator v3.4.0. Removed the previous 'Last Update Submitted that met QC Criteria' label, older No FEAR Act data entry, and older revision indicator v3.3.4.SummaryDifference0.1%

Stay in the know with updates to EDP-305 Safety and Efficacy in NASH Clinical Trial
Enter your email address, and we'll notify you when there's something new on the EDP-305 Safety and Efficacy in NASH Clinical Trial page.